G2 Goldfields Reports "Significant" Gold Discovery Near OKO Project in Guyana-February 2024-www.financetom.com

G2 Goldfields Reports "Significant" Gold Discovery Near OKO Project in Guyana

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

G2 Goldfields Reports "Significant" Gold Discovery Near OKO Project in Guyana

Mar 18, 2025 4:58 AM

07:33 AM EDT, 03/18/2025 (MT Newswires) -- G2 Goldfields ( GUYGF ) on Tuesday reported a significant gold discovery several miles north of the company's existing gold resource at the OKO project in Guyana.

Assays include 24 meters grading 2 grams per tonne (g/t) gold, including 9.3 meters grading 2.8 g/t gold.

The company noted that the new gold discovery lies within properties in the portfolio of its proposed spinoff company G3 Goldfields.

"This is a brand-new discovery from 'first principles' and we look forward to additional exploration success from our team, partners, and portfolio of properties," said Patrick Sheridan, G2's executive chairman.

G2's share price rose 4.8% on Monday to $3.30 on the TSX.

Previous page： Pacira Biosciences Insider Sold Shares Worth $3,656,226, According to a Recent SEC Filing Next page： Xenon Pharmaceuticals Insider Sold Shares Worth $601,615, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Pacira Biosciences Insider Sold Shares Worth $3,656,226, According to a Recent SEC Filing

Mar 8, 2024

05:42 PM EST, 03/08/2024 (MT Newswires) -- Gary W Pace, Director, on March 06, 2024, sold 119,323 shares in Pacira Biosciences ( PCRX ) for $3,656,226. Following the Form 4 filing with the SEC, Pace has control over a total of 22,127 shares of the company, with 22,127 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1396814/000139681424000037/xslF345X03/wk-form4_1709937219.xml Price: 31.55, Change: +0.14, Percent Change:...

Xenon Pharmaceuticals Insider Sold Shares Worth $601,615, According to a Recent SEC Filing

Mar 8, 2024

05:34 PM EST, 03/08/2024 (MT Newswires) -- Steven Gannon, Director, on March 07, 2024, sold 13,000 shares in Xenon Pharmaceuticals ( XENE ) for $601,615. Following the Form 4 filing with the SEC, Gannon has control over a total of 2,000 shares of the company, with 2,000 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1582313/000095017024028788/xslF345X03/ownership.xml ...

Sentinelone Insider Sold Shares Worth $1,880,632, According to a Recent SEC Filing

Mar 8, 2024

05:43 PM EST, 03/08/2024 (MT Newswires) -- Tomer Weingarten, Director, President, CEO, on March 06, 2024, sold 69,427 shares in Sentinelone ( S ) for $1,880,632. Following the Form 4 filing with the SEC, Weingarten has control over a total of 1,285,122 shares of the company, with 1,285,122 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1583708/000186622224000011/xslF345X03/wk-form4_1709937152.xml ...

Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing

Mar 8, 2024

05:43 PM EST, 03/08/2024 (MT Newswires) -- Michael Patrick Donovan, Vice President, Operations, on March 07, 2024, sold 36,310 shares in Axogen ( AXGN ) for $319,891. Following the Form 4 filing with the SEC, Donovan has control over a total of 35,708 shares of the company, with 35,708 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/805928/000080592824000041/xslF345X03/wk-form4_1709937172.xml ...